By Richard A. Lewis, MD
Glaucoma Today asked three surgeons when they revise a bleb.
By Karen Joos, MD, PHD; Jonathan S. Myers, MD; and Barbara Smit, MD, PHD
Two clinicians discuss their approach to selecting IOLs for this patient population.
By Steven D. Vold, MD, and Randall E. Cole, MD
Ologen is a new product that modulates wound healing in glaucoma surgery.
By Steven R. Sarkisian, JR, MD
Glaucoma Today asked several members of the glaucoma community the following question: How do you know whether patients are using their topical glaucoma medications?
By Henry D. Jempel, MD, MHS; Kelly W. Muir, MD; Gary D. Novack, PHD; and Alan L. Robin, MD
For this roundtable discussion, not sponsored by industry, Glaucoma Today convened a panel to discuss needed innovation in glaucoma and the process of protecting new ideas and bringing them to market.
If not protected, an idea will not benefit the creator, and industry will be less likely to have an interest in commercializing the concept.
By Joel S. Schuman, MD, in an Interview with Glaucoma Today
By Nils A. Loewen, MD, PHD
By Michael D. Miscoe, ESQ
By Nathan M. Radcliffe, MD
Dr. Fellman explains his interest in congenital glaucoma and professional service.
Alcon, Inc. (Huenenberg, Switzerland), announced that it has entered into a definitive agreement to acquire Optonol, Ltd. (Neve Ilan, Israel), a medical device company that develops, manufactures, and markets miniature surgica... more >
The Glaucoma Research Foundation (GRF) named Dennis Singleton the 2009 recipient of its Visionary Award. As a long-time member of the GRF’s board, Mr. Singleton was honored for his dedication to the cause of glaucoma researc... more >
Glaucoma Today has applied for Business of Performing Audits (BPA) Worldwide business publication membership. For 12 months, BPA Worldwide will conduct an initial audit of Glaucoma Today’s circulation, which will be tracked ... more >
William H. Swanson, PhD, professor at Indiana University School of Optometry, received a $2.35 million grant from the National Institutes of Health to further his glaucoma research. According to a news release, Dr. Swanson’s... more >
advertisement
Ologen is a new product that modulates wound healing in glaucoma surgery.
by Steven R. Sarkisian, JR, MD
Glaucoma Today asked three surgeons when they revise a bleb.
by Karen Joos, MD, PHD; Jonathan S. Myers, MD; and Barbara Smit, MD, PHD
Two clinicians discuss their approach to selecting IOLs for this patient population.
by Steven D. Vold, MD, and Randall E. Cole, MD
by Nils A. Loewen, MD, PHD
For this roundtable discussion, not sponsored by industry, Glaucoma Today convened a panel to discuss needed innovation in glaucoma and the process of protecting new ideas and bringing them to market.